Denileukin Diftitox in Combination with Rituximab for Previously Untreated Follicular B-cell Non-Hodgkin’s Lymphoma

Follicular lymphoma exhibits intratumoral infiltration by non-malignant T lymphocytes inluding CD4+CD25+ regulatory T (T(reg)) cells. We combined denileukin diftitox with rituximab in previously untreated, advanced-stage follicular lymphoma patients anticipating that denileukin diftitox would deplet...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ansell, Stephen M., Tang, Hui, Kurtin, Paul J., Koenig, Patricia A., Nowakowski, Grzegorz S., Nikcevich, Daniel A., Nelson, Garth D., Yang, Zhizhang, Grote, Deanna M., Ziesmer, Steven C., Silberstein, Peter T., Erlichman, Charles, Witzig, Thomas E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266999/
https://ncbi.nlm.nih.gov/pubmed/22015775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.297
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller